PD-1・PD-L1阻害剤の世界及び中国市場

• 英文タイトル：Global and China PD-1 and PD-L1 Inhibitors Market Insights, Forecast to 2027

• レポートコード：QY2108PAL8909 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、146ページ • 納品方法：Eメール（納期：1日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,170,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の当調査資料ではグローバルにおけるPD-1・PD-L1阻害剤の市場規模（2016年-2027年）と動向についてまとめました。中国市場については主要プレイヤーの市場シェア、PD-1・PD-L1阻害剤の種類別市場規模（PD-1阻害剤、PD-L1阻害剤）、用途別市場規模（固形腫瘍、血液関連腫瘍）も掲載しています。他に、北米・アメリカ市場、ヨーロッパ市場、アジア太平洋・日本市場、中南米市場、中東・アフリカ市場の市場規模、グローバル市場機会・課題・リスク要因、バリューチェーン・販売チャネル、主要プレイヤーの情報なども掲載しています。 ・調査の概要 ・調査のサマリー ・世界のPD-1・PD-L1阻害剤市場動向 ・グローバル主要プレイヤーの競争状況・市場シェア ・世界におけるPD-1・PD-L1阻害剤の種類別市場規模（2016年-2027年）：PD-1阻害剤、PD-L1阻害剤 ・世界におけるPD-1・PD-L1阻害剤の用途別市場規模（2016年-2027年）：固形腫瘍、血液関連腫瘍 ・PD-1・PD-L1阻害剤の中国市場分析 - PD-1・PD-L1阻害剤の中国市場規模（2016年-2027年） - 中国におけるPD-1・PD-L1阻害剤の主要プレイヤー別市場シェア - 中国におけるPD-1・PD-L1阻害剤の種類別市場規模：PD-1阻害剤、PD-L1阻害剤 - 中国におけるPD-1・PD-L1阻害剤の用途別市場規模：固形腫瘍、血液関連腫瘍 ・PD-1・PD-L1阻害剤の北米市場（2016年-2027年） ・PD-1・PD-L1阻害剤のヨーロッパ市場（2016年-2027年） ・PD-1・PD-L1阻害剤のアジア太平洋市場（2016年-2027年） ・PD-1・PD-L1阻害剤の中南米市場（2016年-2027年） ・PD-1・PD-L1阻害剤の中東・アフリカ市場（2016年-2027年） ・主要プレイヤーの情報：Merck、Bristol-Myers Squibb、Roche、AstraZeneca、Ono Pharmaceutical、Regeneron、Innovent、Hengrui Medicine、Junshi Biosciences、Merck KGaA ・市場機会・課題・リスク要因分析 ・バリューチェーン・販売チャネル分析 ・...

PD-1 inhibitors and PD-L1 inhibitors are a group of checkpoint inhibitors being developed for the treatment of cancer. PD-1 and PD-L1 are both proteins present on the surface of cells. Immune checkpoint inhibitors such as these are emerging as a front-line treatment for several types of cancer.
North America is the largest consumption place, with a consumption market share nearly 60.40% in 2019. Following North America, Europe is the second largest consumption place with the consumption market share of 20.66%.Market competition is intense. Merck, Bristol-Myers Squibb, Roche, AstraZeneca, Ono Pharmaceutical etc. are the leaders of the industry.

Market Analysis and Insights: Global and China PD-1 and PD-L1 Inhibitors Market
This report focuses on global and China PD-1 and PD-L1 Inhibitors market.
In 2020, the global PD-1 and PD-L1 Inhibitors market size was US$ 32840 million and it is expected to reach US$ 119290 million by the end of 2027, with a CAGR of 20.2% during 2021-2027. In China the PD-1 and PD-L1 Inhibitors market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.

Global PD-1 and PD-L1 Inhibitors Scope and Market Size
PD-1 and PD-L1 Inhibitors market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global PD-1 and PD-L1 Inhibitors market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For China market, this report focuses on the PD-1 and PD-L1 Inhibitors market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in China.

Segment by Type
PD-1 Inhibitors
PD-L1 Inhibitors

Segment by Application
Solid Tumors
Blood-related Tumors

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

By Company
Merck
Bristol-Myers Squibb
Roche
AstraZeneca
Ono Pharmaceutical
Regeneron
Innovent
Hengrui Medicine
Junshi Biosciences
Merck KGaA

レポート目次

---

1 Study Coverage
1.1 PD-1 and PD-L1 Inhibitors Product Introduction
1.2 Market by Type
1.2.1 Global PD-1 and PD-L1 Inhibitors Market Size Growth Rate by Type
1.2.2 PD-1 Inhibitors
1.2.3 PD-L1 Inhibitors
1.3 Market by Application
1.3.1 Global PD-1 and PD-L1 Inhibitors Market Size Growth Rate by Application
1.3.2 Solid Tumors
1.3.3 Blood-related Tumors
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global PD-1 and PD-L1 Inhibitors Market Size, Estimates and Forecasts
2.1.1 Global PD-1 and PD-L1 Inhibitors Revenue 2016-2027
2.1.2 Global PD-1 and PD-L1 Inhibitors Sales 2016-2027
2.2 Global PD-1 and PD-L1 Inhibitors, Market Size by Region: 2016 VS 2021 VS 2027
2.3 PD-1 and PD-L1 Inhibitors Historical Market Size by Region (2016-2021)
2.3.1 Global PD-1 and PD-L1 Inhibitors Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global PD-1 and PD-L1 Inhibitors Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 PD-1 and PD-L1 Inhibitors Market Estimates and Projections by Region (2022-2027)
2.4.1 Global PD-1 and PD-L1 Inhibitors Sales Forecast by Region (2022-2027)
2.4.2 Global PD-1 and PD-L1 Inhibitors Revenue Forecast by Region (2022-2027)

3 Global PD-1 and PD-L1 Inhibitors Competitor Landscape by Players
3.1 Global Top PD-1 and PD-L1 Inhibitors Manufacturers by Sales
3.1.1 Global PD-1 and PD-L1 Inhibitors Sales by Manufacturer (2016-2021)
3.1.2 Global PD-1 and PD-L1 Inhibitors Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top PD-1 and PD-L1 Inhibitors Manufacturers by Revenue
3.2.1 Key PD-1 and PD-L1 Inhibitors Manufacturers Covered: Ranking by Revenue
3.2.2 Global PD-1 and PD-L1 Inhibitors Revenue by Manufacturers (2016-2021)
3.2.3 Global PD-1 and PD-L1 Inhibitors Revenue Share by Manufacturers (2016-2021)
3.2.4 Global PD-1 and PD-L1 Inhibitors Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by PD-1 and PD-L1 Inhibitors Revenue in 2020
3.2.6 Global PD-1 and PD-L1 Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global PD-1 and PD-L1 Inhibitors Price by Manufacturers
3.4 Global PD-1 and PD-L1 Inhibitors Manufacturing Base Distribution, Product Types
3.4.1 PD-1 and PD-L1 Inhibitors Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers PD-1 and PD-L1 Inhibitors Product Type
3.4.3 Date of International Manufacturers Enter into PD-1 and PD-L1 Inhibitors Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2016-2027)
4.1 Global PD-1 and PD-L1 Inhibitors Market Size by Type (2016-2021)
4.1.1 Global PD-1 and PD-L1 Inhibitors Sales by Type (2016-2021)
4.1.2 Global PD-1 and PD-L1 Inhibitors Revenue by Type (2016-2021)
4.1.3 PD-1 and PD-L1 Inhibitors Average Selling Price (ASP) by Type (2016-2021)
4.2 Global PD-1 and PD-L1 Inhibitors Market Size Forecast by Type (2022-2027)
4.2.1 Global PD-1 and PD-L1 Inhibitors Sales Forecast by Type (2022-2027)
4.2.2 Global PD-1 and PD-L1 Inhibitors Revenue Forecast by Type (2022-2027)
4.2.3 PD-1 and PD-L1 Inhibitors Average Selling Price (ASP) Forecast by Type (2022-2027)

5 Breakdown Data by Application (2016-2027)
5.1 Global PD-1 and PD-L1 Inhibitors Market Size by Application (2016-2021)
5.1.1 Global PD-1 and PD-L1 Inhibitors Sales by Application (2016-2021)
5.1.2 Global PD-1 and PD-L1 Inhibitors Revenue by Application (2016-2021)
5.1.3 PD-1 and PD-L1 Inhibitors Price by Application (2016-2021)
5.2 PD-1 and PD-L1 Inhibitors Market Size Forecast by Application (2022-2027)
5.2.1 Global PD-1 and PD-L1 Inhibitors Sales Forecast by Application (2022-2027)
5.2.2 Global PD-1 and PD-L1 Inhibitors Revenue Forecast by Application (2022-2027)
5.2.3 Global PD-1 and PD-L1 Inhibitors Price Forecast by Application (2022-2027)

6 China by Players, Type and Application
6.1 China PD-1 and PD-L1 Inhibitors Market Size YoY Growth 2016-2027
6.1.1 China PD-1 and PD-L1 Inhibitors Sales YoY Growth 2016-2027
6.1.2 China PD-1 and PD-L1 Inhibitors Revenue YoY Growth 2016-2027
6.1.3 China PD-1 and PD-L1 Inhibitors Market Share in Global Market 2016-2027
6.2 China PD-1 and PD-L1 Inhibitors Market Size by Players (International and Local Players)
6.2.1 China Top PD-1 and PD-L1 Inhibitors Players by Sales (2016-2021)
6.2.2 China Top PD-1 and PD-L1 Inhibitors Players by Revenue (2016-2021)
6.3 China PD-1 and PD-L1 Inhibitors Historic Market Review by Type (2016-2021)
6.3.1 China PD-1 and PD-L1 Inhibitors Sales Market Share by Type (2016-2021)
6.3.2 China PD-1 and PD-L1 Inhibitors Revenue Market Share by Type (2016-2021)
6.3.3 China PD-1 and PD-L1 Inhibitors Price by Type (2016-2021)
6.4 China PD-1 and PD-L1 Inhibitors Market Estimates and Forecasts by Type (2022-2027)
6.4.1 China PD-1 and PD-L1 Inhibitors Sales Forecast by Type (2022-2027)
6.4.2 China PD-1 and PD-L1 Inhibitors Revenue Forecast by Type (2022-2027)
6.4.3 China PD-1 and PD-L1 Inhibitors Price Forecast by Type (2022-2027)
6.5 China PD-1 and PD-L1 Inhibitors Historic Market Review by Application (2016-2021)
6.5.1 China PD-1 and PD-L1 Inhibitors Sales Market Share by Application (2016-2021)
6.5.2 China PD-1 and PD-L1 Inhibitors Revenue Market Share by Application (2016-2021)
6.5.3 China PD-1 and PD-L1 Inhibitors Price by Application (2016-2021)
6.6 China PD-1 and PD-L1 Inhibitors Market Estimates and Forecasts by Application (2022-2027)
6.6.1 China PD-1 and PD-L1 Inhibitors Sales Forecast by Application (2022-2027)
6.6.2 China PD-1 and PD-L1 Inhibitors Revenue Forecast by Application (2022-2027)
6.6.3 China PD-1 and PD-L1 Inhibitors Price Forecast by Application (2022-2027)

7 North America
7.1 North America PD-1 and PD-L1 Inhibitors Market Size YoY Growth 2016-2027
7.2 North America PD-1 and PD-L1 Inhibitors Market Facts & Figures by Country
7.2.1 North America PD-1 and PD-L1 Inhibitors Sales by Country (2016-2021)
7.2.2 North America PD-1 and PD-L1 Inhibitors Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada

8 Asia Pacific
8.1 Asia Pacific PD-1 and PD-L1 Inhibitors Market Size YoY Growth 2016-2027
8.2 Asia Pacific PD-1 and PD-L1 Inhibitors Market Facts & Figures by Region
8.2.1 Asia Pacific PD-1 and PD-L1 Inhibitors Sales by Region (2016-2021)
8.2.2 Asia Pacific PD-1 and PD-L1 Inhibitors Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam

9 Europe
9.1 Europe PD-1 and PD-L1 Inhibitors Market Size YoY Growth 2016-2027
9.2 Europe PD-1 and PD-L1 Inhibitors Market Facts & Figures by Country
9.2.1 Europe PD-1 and PD-L1 Inhibitors Sales by Country (2016-2021)
9.2.2 Europe PD-1 and PD-L1 Inhibitors Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy

10 Latin America
10.1 Latin America PD-1 and PD-L1 Inhibitors Market Size YoY Growth 2016-2027
10.2 Latin America PD-1 and PD-L1 Inhibitors Market Facts & Figures by Country
10.2.1 Latin America PD-1 and PD-L1 Inhibitors Sales by Country (2016-2021)
10.2.2 Latin America PD-1 and PD-L1 Inhibitors Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina

11 Middle East and Africa
11.1 Middle East and Africa PD-1 and PD-L1 Inhibitors Market Size YoY Growth 2016-2027
11.2 Middle East and Africa PD-1 and PD-L1 Inhibitors Market Facts & Figures by Country
11.2.1 Middle East and Africa PD-1 and PD-L1 Inhibitors Sales by Country (2016-2021)
11.2.2 Middle East and Africa PD-1 and PD-L1 Inhibitors Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE

12 Company Profiles
12.1 Merck
12.1.1 Merck Corporation Information
12.1.2 Merck Description and Business Overview
12.1.3 Merck PD-1 and PD-L1 Inhibitors Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Merck PD-1 and PD-L1 Inhibitors Products Offered
12.1.5 Merck Recent Development
12.2 Bristol-Myers Squibb
12.2.1 Bristol-Myers Squibb Corporation Information
12.2.2 Bristol-Myers Squibb Description and Business Overview
12.2.3 Bristol-Myers Squibb PD-1 and PD-L1 Inhibitors Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Bristol-Myers Squibb PD-1 and PD-L1 Inhibitors Products Offered
12.2.5 Bristol-Myers Squibb Recent Development
12.3 Roche
12.3.1 Roche Corporation Information
12.3.2 Roche Description and Business Overview
12.3.3 Roche PD-1 and PD-L1 Inhibitors Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Roche PD-1 and PD-L1 Inhibitors Products Offered
12.3.5 Roche Recent Development
12.4 AstraZeneca
12.4.1 AstraZeneca Corporation Information
12.4.2 AstraZeneca Description and Business Overview
12.4.3 AstraZeneca PD-1 and PD-L1 Inhibitors Sales, Revenue and Gross Margin (2016-2021)
12.4.4 AstraZeneca PD-1 and PD-L1 Inhibitors Products Offered
12.4.5 AstraZeneca Recent Development
12.5 Ono Pharmaceutical
12.5.1 Ono Pharmaceutical Corporation Information
12.5.2 Ono Pharmaceutical Description and Business Overview
12.5.3 Ono Pharmaceutical PD-1 and PD-L1 Inhibitors Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Ono Pharmaceutical PD-1 and PD-L1 Inhibitors Products Offered
12.5.5 Ono Pharmaceutical Recent Development
12.6 Regeneron
12.6.1 Regeneron Corporation Information
12.6.2 Regeneron Description and Business Overview
12.6.3 Regeneron PD-1 and PD-L1 Inhibitors Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Regeneron PD-1 and PD-L1 Inhibitors Products Offered
12.6.5 Regeneron Recent Development
12.7 Innovent
12.7.1 Innovent Corporation Information
12.7.2 Innovent Description and Business Overview
12.7.3 Innovent PD-1 and PD-L1 Inhibitors Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Innovent PD-1 and PD-L1 Inhibitors Products Offered
12.7.5 Innovent Recent Development
12.8 Hengrui Medicine
12.8.1 Hengrui Medicine Corporation Information
12.8.2 Hengrui Medicine Description and Business Overview
12.8.3 Hengrui Medicine PD-1 and PD-L1 Inhibitors Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Hengrui Medicine PD-1 and PD-L1 Inhibitors Products Offered
12.8.5 Hengrui Medicine Recent Development
12.9 Junshi Biosciences
12.9.1 Junshi Biosciences Corporation Information
12.9.2 Junshi Biosciences Description and Business Overview
12.9.3 Junshi Biosciences PD-1 and PD-L1 Inhibitors Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Junshi Biosciences PD-1 and PD-L1 Inhibitors Products Offered
12.9.5 Junshi Biosciences Recent Development
12.10 Merck KGaA
12.10.1 Merck KGaA Corporation Information
12.10.2 Merck KGaA Description and Business Overview
12.10.3 Merck KGaA PD-1 and PD-L1 Inhibitors Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Merck KGaA PD-1 and PD-L1 Inhibitors Products Offered
12.10.5 Merck KGaA Recent Development
12.11 Merck
12.11.1 Merck Corporation Information
12.11.2 Merck Description and Business Overview
12.11.3 Merck PD-1 and PD-L1 Inhibitors Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Merck PD-1 and PD-L1 Inhibitors Products Offered
12.11.5 Merck Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 PD-1 and PD-L1 Inhibitors Industry Trends
13.2 PD-1 and PD-L1 Inhibitors Market Drivers
13.3 PD-1 and PD-L1 Inhibitors Market Challenges
13.4 PD-1 and PD-L1 Inhibitors Market Restraints

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 PD-1 and PD-L1 Inhibitors Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Global PD-1 and PD-L1 Inhibitors Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of PD-1 Inhibitors
Table 3. Major Manufacturers of PD-L1 Inhibitors
Table 4. Global PD-1 and PD-L1 Inhibitors Market Size Growth Rate by Application (2021-2027) & (L)
Table 5. Global PD-1 and PD-L1 Inhibitors Market Size by Region (L) & (US$ Million), 2016 VS 2021 VS 2027
Table 6. Global PD-1 and PD-L1 Inhibitors Sales by Regions (2016-2021) & (L)
Table 7. Global PD-1 and PD-L1 Inhibitors Sales Market Share by Regions (2016-2021)
Table 8. Global PD-1 and PD-L1 Inhibitors Revenue by Regions (2016-2021) & (US$ Million)
Table 9. Global PD-1 and PD-L1 Inhibitors Sales Forecast by Region (2022-2027) & (L)
Table 10. Global PD-1 and PD-L1 Inhibitors Sales Market Share Forecast by Region (2022-2027)
Table 11. Global PD-1 and PD-L1 Inhibitors Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 12. Global PD-1 and PD-L1 Inhibitors Revenue Market Share Forecast by Region (2022-2027)
Table 13. Global PD-1 and PD-L1 Inhibitors Sales by Manufacturers (2016-2021) (L)
Table 14. Global PD-1 and PD-L1 Inhibitors Sales Share by Manufacturers (2016-2021)
Table 15. Ranking of Global Top PD-1 and PD-L1 Inhibitors Manufacturers by Revenue (US$ Million) in 2020
Table 16. PD-1 and PD-L1 Inhibitors Revenue by Manufacturers (2016-2021) (US$ Million)
Table 17. PD-1 and PD-L1 Inhibitors Revenue Share by Manufacturers (2016-2021)
Table 18. Global PD-1 and PD-L1 Inhibitors Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 19. Global PD-1 and PD-L1 Inhibitors by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in PD-1 and PD-L1 Inhibitors as of 2020)
Table 20. Key Manufacturers PD-1 and PD-L1 Inhibitors Price (2016-2021) (USD/ml)
Table 21. PD-1 and PD-L1 Inhibitors Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers PD-1 and PD-L1 Inhibitors Product Type
Table 23. Date of International Manufacturers Enter into PD-1 and PD-L1 Inhibitors Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global PD-1 and PD-L1 Inhibitors Sales by Type (2016-2021) (L)
Table 26. Global PD-1 and PD-L1 Inhibitors Sales Share by Type (2016-2021)
Table 27. Global PD-1 and PD-L1 Inhibitors Revenue by Type (2016-2021) (US$ Million)
Table 28. Global PD-1 and PD-L1 Inhibitors Revenue Share by Type (2016-2021)
Table 29. PD-1 and PD-L1 Inhibitors Average Selling Price (ASP) by Type (2016-2021) & (USD/ml)
Table 30. Global PD-1 and PD-L1 Inhibitors Sales Forecast by Type (2022-2027) & (L)
Table 31. Global PD-1 and PD-L1 Inhibitors Sales Market Share Forecast by Type (2022-2027)
Table 32. Global PD-1 and PD-L1 Inhibitors Revenue Forecast V (2022-2027) & (US$ Million)
Table 33. Global PD-1 and PD-L1 Inhibitors Revenue Market Share Forecast by Type (2022-2027)
Table 34. Global PD-1 and PD-L1 Inhibitors Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/ml)
Table 35. Global PD-1 and PD-L1 Inhibitors Sales by Application (2016-2021) (L)
Table 36. Global PD-1 and PD-L1 Inhibitors Sales Share by Application (2016-2021)
Table 37. Global PD-1 and PD-L1 Inhibitors Revenue by Application (2016-2021) (US$ Million)
Table 38. Global PD-1 and PD-L1 Inhibitors Revenue Share by Application (2016-2021)
Table 39. PD-1 and PD-L1 Inhibitors Average Selling Price (ASP) by Application (2016-2021) & (USD/ml)
Table 40. Global PD-1 and PD-L1 Inhibitors Sales Forecast by Application (2022-2027) & (L)
Table 41. Global PD-1 and PD-L1 Inhibitors Sales Market Share Forecast by Application (2022-2027)
Table 42. Global PD-1 and PD-L1 Inhibitors Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 43. Global PD-1 and PD-L1 Inhibitors Revenue Market Share Forecast by Application (2022-2027)
Table 44. Global PD-1 and PD-L1 Inhibitors Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/ml)
Table 45. China PD-1 and PD-L1 Inhibitors Sales (L) of Key Companies (2016-2021)
Table 46. China PD-1 and PD-L1 Inhibitors Sales Share by Company (2016-2021)
Table 47. China PD-1 and PD-L1 Inhibitors Revenue (US$ Million) by Company (2016-2021)
Table 48. China PD-1 and PD-L1 Inhibitors Revenue Share by Company (2016-2021)
Table 49. China PD-1 and PD-L1 Inhibitors Sales (L) by Type (2016-2021)
Table 50. China PD-1 and PD-L1 Inhibitors Sales Share by Type (2016-2021)
Table 51. China PD-1 and PD-L1 Inhibitors Revenue (US$ Million) Market Share by Type (2016-2021)
Table 52. China PD-1 and PD-L1 Inhibitors Price (USD/ml) by Type (2016-2021)
Table 53. China PD-1 and PD-L1 Inhibitors Sales (L) by Type (2022-2027)
Table 54. China PD-1 and PD-L1 Inhibitors Sales Share by Type (2022-2027)
Table 55. China PD-1 and PD-L1 Inhibitors Revenue (US$ Million) Market Share by Type (2022-2027)
Table 56. China PD-1 and PD-L1 Inhibitors Revenue Share by Type (2022-2027)
Table 57. China PD-1 and PD-L1 Inhibitors Price (USD/ml) by Type (2022-2027)
Table 58. China PD-1 and PD-L1 Inhibitors Sales (L) by Application (2016-2021)
Table 59. China PD-1 and PD-L1 Inhibitors Sales Share by Application (2016-2021)
Table 60. China PD-1 and PD-L1 Inhibitors Revenue (US$ Million) Market Share by Application (2016-2021)
Table 61. China PD-1 and PD-L1 Inhibitors Price (USD/ml) by Application (2016-2021)
Table 62. China PD-1 and PD-L1 Inhibitors Sales (L) by Application (2022-2027)
Table 63. China PD-1 and PD-L1 Inhibitors Sales Share by Application (2022-2027)
Table 64. China PD-1 and PD-L1 Inhibitors Revenue (US$ Million) Market Share by Application (2022-2027)
Table 65. China PD-1 and PD-L1 Inhibitors Revenue Share by Application (2022-2027)
Table 66. China PD-1 and PD-L1 Inhibitors Price (USD/ml) by Application (2022-2027)
Table 67. North America PD-1 and PD-L1 Inhibitors Sales by Country (2016-2021) & (L)
Table 68. North America PD-1 and PD-L1 Inhibitors Sales Market Share by Country (2016-2021)
Table 69. North America PD-1 and PD-L1 Inhibitors Revenue by Country (2016-2021) & (US$ Million)
Table 70. North America PD-1 and PD-L1 Inhibitors Revenue Market Share by Country (2016-2021)
Table 71. Asia Pacific PD-1 and PD-L1 Inhibitors Sales by Region (2016-2021) & (L)
Table 72. Asia Pacific PD-1 and PD-L1 Inhibitors Sales Market Share by Region (2016-2021)
Table 73. Asia Pacific PD-1 and PD-L1 Inhibitors Revenue by Region (2016-2021) & (US$ Million)
Table 74. Asia Pacific PD-1 and PD-L1 Inhibitors Revenue Market Share by Region (2016-2021)
Table 75. Europe PD-1 and PD-L1 Inhibitors Sales by Country (2016-2021) & (L)
Table 76. Europe PD-1 and PD-L1 Inhibitors Sales Market Share by Country (2016-2021)
Table 77. Europe PD-1 and PD-L1 Inhibitors Revenue by Country (2016-2021) & (US$ Million)
Table 78. Europe PD-1 and PD-L1 Inhibitors Revenue Market Share by Country (2016-2021)
Table 79. Latin America PD-1 and PD-L1 Inhibitors Sales by Country (2016-2021) & (L)
Table 80. Latin America PD-1 and PD-L1 Inhibitors Sales Market Share by Country (2016-2021)
Table 81. Latin Americaa PD-1 and PD-L1 Inhibitors Revenue by Country (2016-2021) & (US$ Million)
Table 82. Latin America PD-1 and PD-L1 Inhibitors Revenue Market Share by Country (2016-2021)
Table 83. Middle East and Africa PD-1 and PD-L1 Inhibitors Sales by Country (2016-2021) & (L)
Table 84. Middle East and Africa PD-1 and PD-L1 Inhibitors Sales Market Share by Country (2016-2021)
Table 85. Middle East and Africa PD-1 and PD-L1 Inhibitors Revenue by Country (2016-2021) & (US$ Million)
Table 86. Middle East and Africa PD-1 and PD-L1 Inhibitors Revenue Market Share by Country (2016-2021)
Table 87. Merck Corporation Information
Table 88. Merck Description and Business Overview
Table 89. Merck PD-1 and PD-L1 Inhibitors Sales (L), Revenue (US$ Million), Price (USD/ml) and Gross Margin (2016-2021)
Table 90. Merck PD-1 and PD-L1 Inhibitors Product
Table 91. Merck Recent Development
Table 92. Bristol-Myers Squibb Corporation Information
Table 93. Bristol-Myers Squibb Description and Business Overview
Table 94. Bristol-Myers Squibb PD-1 and PD-L1 Inhibitors Sales (L), Revenue (US$ Million), Price (USD/ml) and Gross Margin (2016-2021)
Table 95. Bristol-Myers Squibb Product
Table 96. Bristol-Myers Squibb Recent Development
Table 97. Roche Corporation Information
Table 98. Roche Description and Business Overview
Table 99. Roche PD-1 and PD-L1 Inhibitors Sales (L), Revenue (US$ Million), Price (USD/ml) and Gross Margin (2016-2021)
Table 100. Roche Product
Table 101. Roche Recent Development
Table 102. AstraZeneca Corporation Information
Table 103. AstraZeneca Description and Business Overview
Table 104. AstraZeneca PD-1 and PD-L1 Inhibitors Sales (L), Revenue (US$ Million), Price (USD/ml) and Gross Margin (2016-2021)
Table 105. AstraZeneca Product
Table 106. AstraZeneca Recent Development
Table 107. Ono Pharmaceutical Corporation Information
Table 108. Ono Pharmaceutical Description and Business Overview
Table 109. Ono Pharmaceutical PD-1 and PD-L1 Inhibitors Sales (L), Revenue (US$ Million), Price (USD/ml) and Gross Margin (2016-2021)
Table 110. Ono Pharmaceutical Product
Table 111. Ono Pharmaceutical Recent Development
Table 112. Regeneron Corporation Information
Table 113. Regeneron Description and Business Overview
Table 114. Regeneron PD-1 and PD-L1 Inhibitors Sales (L), Revenue (US$ Million), Price (USD/ml) and Gross Margin (2016-2021)
Table 115. Regeneron Product
Table 116. Regeneron Recent Development
Table 117. Innovent Corporation Information
Table 118. Innovent Description and Business Overview
Table 119. Innovent PD-1 and PD-L1 Inhibitors Sales (L), Revenue (US$ Million), Price (USD/ml) and Gross Margin (2016-2021)
Table 120. Innovent Product
Table 121. Innovent Recent Development
Table 122. Hengrui Medicine Corporation Information
Table 123. Hengrui Medicine Description and Business Overview
Table 124. Hengrui Medicine PD-1 and PD-L1 Inhibitors Sales (L), Revenue (US$ Million), Price (USD/ml) and Gross Margin (2016-2021)
Table 125. Hengrui Medicine Product
Table 126. Hengrui Medicine Recent Development
Table 127. Junshi Biosciences Corporation Information
Table 128. Junshi Biosciences Description and Business Overview
Table 129. Junshi Biosciences PD-1 and PD-L1 Inhibitors Sales (L), Revenue (US$ Million), Price (USD/ml) and Gross Margin (2016-2021)
Table 130. Junshi Biosciences Product
Table 131. Junshi Biosciences Recent Development
Table 132. Merck KGaA Corporation Information
Table 133. Merck KGaA Description and Business Overview
Table 134. Merck KGaA PD-1 and PD-L1 Inhibitors Sales (L), Revenue (US$ Million), Price (USD/ml) and Gross Margin (2016-2021)
Table 135. Merck KGaA Product
Table 136. Merck KGaA Recent Development
Table 137. PD-1 and PD-L1 Inhibitors Market Trends
Table 138. PD-1 and PD-L1 Inhibitors Market Drivers
Table 139. PD-1 and PD-L1 Inhibitors Market Challenges
Table 140. PD-1 and PD-L1 Inhibitors Market Restraints
Table 141. PD-1 and PD-L1 Inhibitors Customers List
Table 142. PD-1 and PD-L1 Inhibitors Distributors List
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. PD-1 and PD-L1 Inhibitors Product Picture
Figure 2. Global PD-1 and PD-L1 Inhibitors Sales Market Share by Type in 2020 & 2027
Figure 3. PD-1 Inhibitors Product Picture
Figure 4. PD-L1 Inhibitors Product Picture
Figure 5. Global PD-1 and PD-L1 Inhibitors Sales Market Share by Application in 2020 & 2027
Figure 6. Solid Tumors
Figure 7. Blood-related Tumors
Figure 8. PD-1 and PD-L1 Inhibitors Report Years Considered
Figure 9. Global PD-1 and PD-L1 Inhibitors Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global PD-1 and PD-L1 Inhibitors Market Size 2016-2027 (US$ Million)
Figure 11. Global PD-1 and PD-L1 Inhibitors Sales 2016-2027 (L)
Figure 12. Global PD-1 and PD-L1 Inhibitors Market Size Market Share by Region: 2021 Versus 2027
Figure 13. Global PD-1 and PD-L1 Inhibitors Sales Market Share by Region (2016-2021)
Figure 14. Global PD-1 and PD-L1 Inhibitors Sales Market Share by Region in 2020
Figure 15. Global PD-1 and PD-L1 Inhibitors Revenue Market Share by Region (2016-2021)
Figure 16. Global PD-1 and PD-L1 Inhibitors Revenue Market Share by Region in 2020
Figure 17. Global PD-1 and PD-L1 Inhibitors Sales Share by Manufacturer in 2020
Figure 18. The Top 10 and 5 Players Market Share by PD-1 and PD-L1 Inhibitors Revenue in 2020
Figure 19. PD-1 and PD-L1 Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 20. Global PD-1 and PD-L1 Inhibitors Sales Market Share by Type (2016-2021)
Figure 21. Global PD-1 and PD-L1 Inhibitors Sales Market Share by Type in 2020
Figure 22. Global PD-1 and PD-L1 Inhibitors Revenue Market Share by Type (2016-2021)
Figure 23. Global PD-1 and PD-L1 Inhibitors Revenue Market Share by Type in 2020
Figure 24. Global PD-1 and PD-L1 Inhibitors Sales Market Share by Application (2016-2021)
Figure 25. Global PD-1 and PD-L1 Inhibitors Sales Market Share by Application in 2020
Figure 26. Global PD-1 and PD-L1 Inhibitors Revenue Market Share by Application (2016-2021)
Figure 27. Global PD-1 and PD-L1 Inhibitors Revenue Market Share by Application in 2020
Figure 28. China PD-1 and PD-L1 Inhibitors Sales Growth Rate 2016-2027 (L)
Figure 29. China PD-1 and PD-L1 Inhibitors Revenue Growth Rate 2016-2027 (US$ Million)
Figure 30. China PD-1 and PD-L1 Inhibitors Market Share in Global Market 2016-2027
Figure 31. China 5 and 10 Largest PD-1 and PD-L1 Inhibitors Players Market Share by Revenue in PD-1 and PD-L1 Inhibitors in 2020
Figure 32. China PD-1 and PD-L1 Inhibitors Revenue Share by Type (2016-2021)
Figure 33. China PD-1 and PD-L1 Inhibitors Revenue Growth Rate by Type in 2016 & 2020
Figure 34. China PD-1 and PD-L1 Inhibitors Revenue Share by Application (2016-2021)
Figure 35. China PD-1 and PD-L1 Inhibitors Revenue Growth Rate by Application in 2016 & 2020
Figure 36. North America PD-1 and PD-L1 Inhibitors Sales Growth Rate 2016-2021 (L)
Figure 37. North America PD-1 and PD-L1 Inhibitors Revenue Growth Rate 2016-2021 (US$ Million)
Figure 38. North America PD-1 and PD-L1 Inhibitors Sales Market Share by Country in 2020
Figure 39. North America PD-1 and PD-L1 Inhibitors Revenue Market Share by Country in 2020
Figure 40. U.S. PD-1 and PD-L1 Inhibitors Sales Growth Rate (2016-2021) (L)
Figure 41. U.S. PD-1 and PD-L1 Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Canada PD-1 and PD-L1 Inhibitors Sales Growth Rate (2016-2021) (L)
Figure 43. Canada PD-1 and PD-L1 Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Europe PD-1 and PD-L1 Inhibitors Sales Growth Rate 2016-2021 (L)
Figure 45. Europe PD-1 and PD-L1 Inhibitors Revenue Growth Rate 2016-2021 (US$ Million)
Figure 46. Europe PD-1 and PD-L1 Inhibitors Sales Market Share by Country in 2020
Figure 47. Europe PD-1 and PD-L1 Inhibitors Revenue Market Share by Country in 2020
Figure 48. Germany PD-1 and PD-L1 Inhibitors Sales Growth Rate (2016-2021) (L)
Figure 49. Germany PD-1 and PD-L1 Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 50. France PD-1 and PD-L1 Inhibitors Sales Growth Rate (2016-2021) (L)
Figure 51. France PD-1 and PD-L1 Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 52. U.K. PD-1 and PD-L1 Inhibitors Sales Growth Rate (2016-2021) (L)
Figure 53. U.K. PD-1 and PD-L1 Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 54. Italy PD-1 and PD-L1 Inhibitors Sales Growth Rate (2016-2021) (L)
Figure 55. Italy PD-1 and PD-L1 Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 56. Russia PD-1 and PD-L1 Inhibitors Sales Growth Rate (2016-2021) (L)
Figure 57. Russia PD-1 and PD-L1 Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 58. Asia Pacific PD-1 and PD-L1 Inhibitors Sales Growth Rate 2016-2021 (L)
Figure 59. Asia Pacific PD-1 and PD-L1 Inhibitors Revenue Growth Rate 2016-2021 (US$ Million)
Figure 60. Asia Pacific PD-1 and PD-L1 Inhibitors Sales Market Share by Region in 2020
Figure 61. Asia Pacific PD-1 and PD-L1 Inhibitors Revenue Market Share by Region in 2020
Figure 62. China PD-1 and PD-L1 Inhibitors Sales Growth Rate (2016-2021) (L)
Figure 63. China PD-1 and PD-L1 Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 64. Japan PD-1 and PD-L1 Inhibitors Sales Growth Rate (2016-2021) (L)
Figure 65. Japan PD-1 and PD-L1 Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 66. South Korea PD-1 and PD-L1 Inhibitors Sales Growth Rate (2016-2021) (L)
Figure 67. South Korea PD-1 and PD-L1 Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 68. India PD-1 and PD-L1 Inhibitors Sales Growth Rate (2016-2021) (L)
Figure 69. India PD-1 and PD-L1 Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 70. Australia PD-1 and PD-L1 Inhibitors Sales Growth Rate (2016-2021) (L)
Figure 71. Australia PD-1 and PD-L1 Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 72. Taiwan PD-1 and PD-L1 Inhibitors Sales Growth Rate (2016-2021) (L)
Figure 73. Taiwan PD-1 and PD-L1 Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 74. Indonesia PD-1 and PD-L1 Inhibitors Sales Growth Rate (2016-2021) (L)
Figure 75. Indonesia PD-1 and PD-L1 Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 76. Thailand PD-1 and PD-L1 Inhibitors Sales Growth Rate (2016-2021) (L)
Figure 77. Thailand PD-1 and PD-L1 Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 78. Malaysia PD-1 and PD-L1 Inhibitors Sales Growth Rate (2016-2021) (L)
Figure 79. Malaysia PD-1 and PD-L1 Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 80. Philippines PD-1 and PD-L1 Inhibitors Sales Growth Rate (2016-2021) (L)
Figure 81. Philippines PD-1 and PD-L1 Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 82. Vietnam PD-1 and PD-L1 Inhibitors Sales Growth Rate (2016-2021) (L)
Figure 83. Vietnam PD-1 and PD-L1 Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 84. Latin America PD-1 and PD-L1 Inhibitors Sales Growth Rate 2016-2021 (L)
Figure 85. Latin America PD-1 and PD-L1 Inhibitors Revenue Growth Rate 2016-2021 (US$ Million)
Figure 86. Latin America PD-1 and PD-L1 Inhibitors Sales Market Share by Country in 2020
Figure 87. Latin America PD-1 and PD-L1 Inhibitors Revenue Market Share by Country in 2020
Figure 88. Mexico PD-1 and PD-L1 Inhibitors Sales Growth Rate (2016-2021) (L)
Figure 89. Mexico PD-1 and PD-L1 Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 90. Brazil PD-1 and PD-L1 Inhibitors Sales Growth Rate (2016-2021) (L)
Figure 91. Brazil PD-1 and PD-L1 Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 92. Argentina PD-1 and PD-L1 Inhibitors Sales Growth Rate (2016-2021) (L)
Figure 93. Argentina PD-1 and PD-L1 Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 94. Middle East and Africa PD-1 and PD-L1 Inhibitors Sales Growth Rate 2016-2021 (L)
Figure 95. Middle East and Africa PD-1 and PD-L1 Inhibitors Revenue Growth Rate 2016-2021 (US$ Million)
Figure 96. Middle East and Africa PD-1 and PD-L1 Inhibitors Sales Market Share by Country in 2020
Figure 97. Middle East and Africa PD-1 and PD-L1 Inhibitors Revenue Market Share by Country in 2020
Figure 98. Turkey PD-1 and PD-L1 Inhibitors Sales Growth Rate (2016-2021) (L)
Figure 99. Turkey PD-1 and PD-L1 Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 100. Saudi Arabia PD-1 and PD-L1 Inhibitors Sales Growth Rate (2016-2021) (L)
Figure 101. Saudi Arabia PD-1 and PD-L1 Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 102. UAE PD-1 and PD-L1 Inhibitors Sales Growth Rate (2016-2021) (L)
Figure 103. UAE PD-1 and PD-L1 Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 104. PD-1 and PD-L1 Inhibitors Value Chain
Figure 105. Channels of Distribution
Figure 106. Distributors Profiles
Figure 107. Bottom-up and Top-down Approaches for This Report
Figure 108. Data Triangulation
Figure 109. Key Executives Interviewed

---